State Street’s Traws Pharma TRAW Stock Holding History

State Street’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.8K	Hold	25,802	–	–	﹤0.01%	4129
2026 Q1	$47.2K	Hold	25,802	–	–	﹤0.01%	4134
2025 Q4	$29.2K	Buy	+25,802	New	+$57.4K	﹤0.01%	4212
2024 Q3	–	Sell	-2,404	Closed	-$26.8K	–	4347
2024 Q2	$26.8K	Buy	2,404 +292	+14%	+$4.71K	﹤0.01%	4241
2024 Q1	$53.3K	Hold	2,112	–	–	﹤0.01%	4149
2023 Q4	$39.4K	Hold	2,112	–	–	﹤0.01%	4243
2023 Q3	$38.1K	Hold	2,112	–	–	﹤0.01%	4342
2023 Q2	$62.3K	Hold	2,112	–	–	﹤0.01%	4362
2023 Q1	$38.6K	Hold	2,112	–	–	﹤0.01%	4568
2022 Q4	$33.9K	Hold	2,112	–	–	﹤0.01%	4641
2022 Q3	$47K	Hold	2,112	–	–	﹤0.01%	4672
2022 Q2	$70K	Buy	2,112 +96	+5%	+$3.24K	﹤0.01%	4650
2022 Q1	$93K	Hold	2,016	–	–	﹤0.01%	4662
2021 Q4	$128K	Hold	2,016	–	–	﹤0.01%	4516
2021 Q3	$193K	Sell	2,016 -2,588	-56%	-$333K	﹤0.01%	4370
2021 Q2	$798K	Buy	4,604 +4,356	+1,756%	+$986K	﹤0.01%	3706
2021 Q1	$93K	Buy	+248	New	+$93.5K	﹤0.01%	3908
2014 Q2	–	Sell	-1	Closed	-$453K	–	3676
2014 Q1	$453K	Hold	1	–	–	﹤0.01%	3376
2013 Q4	$708K	Hold	1	–	–	﹤0.01%	3307
2013 Q3	$1.2M	Buy	+1	New	+$1.43M	﹤0.01%	3215

Other funds holding TRAW

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

State Street's TRAW Position: Q2 2026 in Review

State Street held its Traws Pharma (TRAW) position steady in Q2 2026 at 25,802 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4129.

State Street first reported a position in TRAW in Q3 2013 and has held it in 20 quarters since. The position peaked at $1.2M in Q3 2013. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

State Street held 25,802 shares of Traws Pharma worth $21.8K as of Q2 2026.
State Street left its Traws Pharma share count unchanged in Q2 2026.
Traws Pharma made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4129 holding.
State Street first reported a position in Traws Pharma in Q3 2013 and has held it in 20 quarters since.
State Street's Traws Pharma position peaked at $1.2M in Q3 2013.
35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.